Promising Results in Drug Therapy
A recent British study has shown encouraging results for a new drug treatment targeting one of the hormonal causes of high blood pressure, indicating that its effect in lowering the levels of the hormone responsible for the condition may persist even after discontinuation. According to the study conducted by researchers from Queen Mary University in London and published yesterday, Saturday, in the medical journal "The New England Journal of Medicine," the treatment aims to reduce the production of aldosterone, whose elevated levels lead to sodium and water retention in the body, contributing to increased blood pressure.
Significant Drop in Biomarkers
The study results showed a 99 percent reduction in one biomarker associated with increased aldosterone production, alongside an average blood pressure drop of about 25 points, with some participants achieving normal blood pressure levels without the need for additional medications. Researchers clarified that the importance of the treatment lies in targeting the hormonal mechanism causing high blood pressure, rather than merely lowering its levels, which may offer a new therapeutic option for patients suffering from aldosterone overproduction.
Need for Broader Studies
Despite the encouraging results, researchers pointed out the necessity of conducting broader studies on larger numbers of patients to evaluate the treatment's efficacy and long-term safety before approving its widespread use. High blood pressure is considered a major risk factor for cardiovascular diseases, while treatments targeting its direct causes represent one of the research pathways to develop more effective means of controlling it.
Source: Syrian Arab News Agency (SANA)
Comments (0)